###begin article-title 0
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Vpr protein from HIV-1: distinct roles along the viral life cycle
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 171 174 171 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tat</italic>
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rev</italic>
###xml 181 184 181 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif</italic>
###xml 191 194 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpr</italic>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpx </italic>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpu</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tat </italic>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rev </italic>
###xml 307 310 307 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 312 315 312 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vif</italic>
###xml 317 326 317 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpr, vpx </italic>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpu </italic>
###xml 473 482 473 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 578 585 578 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 595 598 595 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpr</italic>
###xml 604 607 604 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpx</italic>
###xml 790 794 790 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpr </italic>
###xml 840 844 840 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpr </italic>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 58 61 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 66 69 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 655 660 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 731 736 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 849 854 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The genomes of human and simian immunodeficiency viruses (HIV and SIV) encode the gag, pol and env genes and contain at least six supplementary open reading frames termed tat, rev, nef, vif, vpr, vpx and vpu. While the tat and rev genes encode regulatory proteins absolutely required for virus replication, nef, vif, vpr, vpx and vpu encode for small proteins referred to "auxiliary" (or "accessory"), since their expression is usually dispensable for virus growth in many in vitro systems. However, these auxiliary proteins are essential for viral replication and pathogenesis in vivo. The two vpr- and vpx-related genes are found only in members of the HIV-2/SIVsm/SIVmac group, whereas primate lentiviruses from other lineages (HIV-1, SIVcpz, SIVagm, SIVmnd and SIVsyk) contain a single vpr gene. In this review, we will mainly focus on vpr from HIV-1 and discuss the most recent developments in our understanding of Vpr functions and its role during the virus replication cycle.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpr </italic>
###xml 547 548 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 549 550 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 616 620 616 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpr </italic>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpx </italic>
###xml 714 715 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 716 717 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 736 744 736 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 828 836 828 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 838 846 838 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 850 858 850 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 1338 1339 1338 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 113 118 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 120 125 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 130 133 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 358 372 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 475 478 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 587 590 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1297 1300 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1473 1481 <span type="species:ncbi:9606">patients</span>
The viral protein R (Vpr) of HIV-1 is a small basic protein (14 kDa) of 96 amino acids, and is well conserved in HIV-1, HIV-2 and SIV [1]. The role of Vpr in the pathogenesis of AIDS is undeniable, but its real functions during the natural course of infection are still subject to debate. The Vpr role in the pathophysiology of AIDS has been investigated in rhesus monkeys experimentally infected with SIVmac, and it was initially shown that monkeys infected with a vpr null SIV mutant decreased virus replication and delayed disease progression [2,3]. Moreover, monkeys infected with a SIV that did not express the vpr and vpx genes displayed a very low virus burden and did not develop immunodeficiency disease [4,5]. Regarding these in vivo phenotypic effects, numerous laboratories have dissected the role of Vpr in various in vitro, in vivo and ex vivo systems to explore the contribution of this protein in the different steps of the virus life cycle. Despite its small size, Vpr has been shown to play multiple functions during virus replication, including an effect on the accuracy of the reverse-transcription process, the nuclear import of the viral DNA as a component of the pre-integration complex (PIC), cell cycle progression, regulation of apoptosis, and the transactivation of the HIV-LTR as well as host cell genes (Fig. 1). Furthermore, Vpr is found in virions, in cells, and exists as free molecules found in the sera and the cerebrospinal fluid of AIDS patients, indicating that it may exert its biological functions through different manners.
###end p 4
###begin p 5
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 463 466 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Schematic view of the early steps of the HIV-1 infection of a target cell. The functional events in which the Vpr protein is involved are highlighted. Vpr has been shown to play multiple functions during the virus life cycle, including an effect on the accuracy of the reverse-transcription process, the nuclear import of the viral DNA as a component of the pre-integration complex, cell cycle progression, regulation of apoptosis, and the transactivation of the HIV-LTR as well as host cell genes.
###end p 5
###begin title 6
###xml 17 22 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structure of the HIV-1 Vpr protein
###end title 6
###begin p 7
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 476 477 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 592 593 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 702 704 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 767 768 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 769 771 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 772 774 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 827 829 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 989 990 973 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1145 1147 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1355 1365 1335 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis/trans </italic>
###xml 1415 1417 1395 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1616 1618 1596 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1908 1909 1888 1889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1910 1912 1890 1892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1913 1915 1893 1895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1057 1062 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Because the full length protein aggregated in aqueous solution, the overall structure of Vpr has been difficult to access [6], and preliminary strategies used two distinct synthetic peptides corresponding to Vpr (1-51) and (52-96) fragments for NMR and circular dichroism studies [6-9]. As previously predicted [10], the structure of the Vpr(1-51) fragment has a long motif of alpha helix turn-alpha helix type encompassing the Asp17-Ile46 region, and ends with a gamma turn [8]. The Vpr(52-96) fragment contains an alpha-helix encompassing the 53-78 region that is rich in leucine residues [7]. One side of the helix offers a stretch of hydrophobic residues that can form a leucine-zipper like motif [11]. This structure may account for the formation of Vpr dimers [7,12,13] and/or for the interaction with cellular partners [14]. Finally, NMR analysis of a soluble full length Vpr (1-96) polypeptide was recently performed, and gave access to the tertiary structure of the protein (Fig. 2), confirming the amphipathic nature of the three alpha-helices of HIV-1 Vpr. The helices are connected by loops and are folded around a hydrophobic core [15] surrounded by a flexible N-terminal domain and a C-terminal arginine-rich region that are negatively and positively charged, respectively. Four conserved prolines (positions 5, 10, 14 and 35) which present cis/trans isomerization are found in the N-terminal domain [16]. It was reported that the cellular peptidyl-propyl isomerase cyclophilin A was able to interact with Vpr via prolines in position 14 and 35, which insured the correct folding of the viral protein [17]. The carboxy-terminus of Vpr contains six arginines between residues 73 and 96. This domain shows similarity with those of arginine-rich protein transduction domains (PTD), and may explain the transducing properties of Vpr, including its ability to cross the cell membrane lipid bilayer [6,18-20].
###end p 7
###begin p 8
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Three-dimensional structure of the HIV-1 Vpr protein (from [15]). The three alpha-helices (17-33, 38-50, 55-77) are colored in pink, blue and orange, respectively; the loops and flexible domains are in green. We can the Trp54 residue localized between the second and the third a-helix, and that is likely accessible for protein-protein interaction with UNG2 [54].
###end p 8
###begin title 9
Vpr is packaged into virus particles
###end title 9
###begin p 10
###xml 286 290 286 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 304 307 304 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag</italic>
###xml 320 324 320 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 441 443 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 482 486 478 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 504 508 500 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 568 570 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 571 573 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 623 627 619 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 753 755 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 756 758 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 811 813 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 814 816 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 905 907 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 908 910 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 911 913 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 959 961 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 962 964 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 995 999 991 995 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1220 1224 1216 1220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1256 1260 1252 1256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1409 1411 1405 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1412 1414 1408 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1443 1445 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1538 1540 1534 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
Vpr is expressed at a late stage of the virus life cycle, but it is present during the early steps of infection of target cells since it is packaged into virions released from the producing cells. The incorporation of Vpr occurs through a direct interaction with the carboxy-terminal p6Gag region of the gag-encoded Pr55Gag precursor [21-24]. While the integrity of the alpha-helices of Vpr is required for efficient packaging into virions [25], a leucine-rich motif found in the p6Gag region of the Pr55Gag precursor is directly involved in the interaction with Vpr [23,26]. After assembly and proteolytic cleavage of Pr55Gag in matrix, capsid, nucleocapsid (NCp7), and p6 mature proteins, Vpr is recruited into the conical core of the virus particle [27,28] where it is tightly associated with the viral RNA [29,30]. Interestingly, Vpr displays a higher avidity for NCp7 than for the mature p6 protein [23,24,31]. Since p6 is excluded from the virion core [27,28], Vpr could switch from the p6Gag region of the precursor to the mature NCp7 protein to gain access to the core of the infectious virus particle budding at the cell surface. It seems that Vpr is less avid for the fully processed p6 protein than for the p6Gag region in the context of the p55Gag precursor. Because of this differential avidity, Vpr is recruited into to the core of the particle where it could interact with nucleic acids, NCp7 [24,31] and/or the matrix protein [32]. Since it was estimated that Vpr is efficiently incorporated with a Vpr/Gag ratio of ~1:7 [33], that may represent 275 molecules of Vpr per virion.
###end p 10
###begin p 11
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 335 344 335 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in trans </italic>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
The incorporation of Vpr has been also used as a unique tool to target cargoes (i.e., cellular and viral proteins, drugs) into viral particles [34,35]. This property was extensively used to study the respective functions of integrase (IN) and reverse transcriptase (RT) during virus replication by expressing Vpr-IN and Vpr-RT fusions in trans in virus-producing cells [36-38]. This strategy of trans-complementation also allowed the analysis of mutant of IN without altering assembly, maturation and other subsequent viral events [37,39].
###end p 11
###begin p 12
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 93 96 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Furthermore, Vpr fused to the green fluorescence protein (GFP) has been recently used to tag HIV particles in order to follow intracellular virus behavior during the early steps of infection of target cells [40,41].
###end p 12
###begin title 13
Vpr influences the fidelity of the reverse transcription process
###end title 13
###begin p 14
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 877 879 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 772 777 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Following virus entry, the viral core is released into the cytoplasm of the target cell and the reverse transcription of the viral RNA takes place in the cytoplasm within a large nucleoprotein complex termed the reverse transcription complex (RTC) containing the two copies of viral RNA and the viral proteins: RT, IN, NCp7, Vpr and a few molecules of the matrix protein [42-46]. It is generally believed that the reverse transcription process is initiated in virus particles and is then completed, after virus entry, in the cystosol of the target cell. This process is likely concomitant of both virus uncoating and trafficking through the cytosol (for reviews, see [47,48]). Recent studies confirmed that Vpr co-localizes with viral nucleic acids and IN within purified HIV-1 RTCs [41,45,49], and remains associated with the viral DNA within 4 to 16 h after acute infection [43].
###end p 14
###begin p 15
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 315 323 315 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 761 763 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1209 1218 1209 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1222 1230 1222 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 1715 1717 1711 1713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1718 1720 1714 1716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 164 169 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 232 237 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 735 740 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1117 1122 <span type="species:ncbi:4932">yeast</span>
###xml 1371 1376 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In addition to a potential role in the initiation step of the reverse transcription process [50], it has been shown that Vpr modulates the in vivo mutation rate of HIV-1 by influencing the accuracy of the reverse transcription. The HIV-1 RT is an error-prone RNA dependant DNA polymerase, and quantification of the in vivo rate of forward virus mutation per replication cycle revealed that the mutation rate was as much as fourfold higher in the absence of Vpr expression when measured in actively dividing cells using a genetically engineered system [51,52]. Furthermore, recent analysis in non-dividing cells shows that this phenotype is exacerbated in primary monocyte-derived macrophages (MDM) leading to a 18-fold increase of the HIV-1 mutation frequency [53]. This activity strikingly correlates with the interaction of Vpr with the nuclear form of uracil DNA glycosylase (UNG2) [54], an enzyme involved in the base excision repair pathway that specifically removes the RNA base uracil from DNA. Uracil can occur in DNA either by misincorporation of dUTP or by cytosine deamination. Initially identified from a yeast two-hybrid screening using Vpr as a bait, the interaction with UNG was confirmed both in vitro and ex vivo in Vpr-expressing cells. While the Trp residue in position 54 located in the exposed loop connecting the second and the third alpha-helix of HIV-1 Vpr has been shown critical to maintain the interaction with UNG, the Vpr-binding site was mapped within the C-terminal part of UNG2 and occurs through a TrpXXPhe motif. Currently, three distinct cellular partners of Vpr contain a WXXF motif including the TFIIB transcription factor, the adenosine-nucleotide translocator (ANT) and UNG2 [55,56].
###end p 15
###begin p 16
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1696 1705 1696 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 121 126 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 845 850 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1165 1170 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1267 1272 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The association of Vpr with UNG2 in virus-producing cells allows the incorporation of a catalytically active enzyme into HIV-1 particles where UNG2 may directly influence the reverse transcription accuracy [54], and this plays a specific role in the modulation of the virus mutation rate. The model supporting the direct contribution of incorporated UNG2 in the reverse transcription process was recently demonstrated by using an experimental system in which UNG2 was recruited into virions independently of Vpr. UNG2 was expressed as a chimeric protein fused to the C-terminal extremity of the VprW54R mutant, a Vpr variant that fails to recruit UNG2 into virions and to influence the virus mutation rate, even though it is incorporated as efficiently as the wild type (wt) Vpr protein. The VprW54R-UNG fusion is also efficiently packaged into HIV-1 virions and restores a mutation rate equivalent to that observed with the wt Vpr, both in actively dividing cells and in MDMs. In agreement with this phenotype on the virus mutation frequency, it was finally documented that the Vpr-mediated incorporation of UNG2 into virus particles contributes to the ability of HIV-1 to replicate in primary macrophages. When the VprW54R variant was introduced into an infectious HIV-1 molecular clone, virus replication in MDMs was both reduced and delayed whereas replication in PBMC was not altered by the lack of UNG2 incorporation into virus particles. Although it was proposed that the viral integrase was also able to mediate interaction with UNG2, Vpr seems the main viral determinant that allows for the incorporation of cellular UNG2 into virus particles. However, preliminary results obtained from in vitro binding assays suggest that both Vpr and IN associate with UNG to form a trimeric complex (ELR and SB, unpublished results), but further analyses are required to document the nature of the interactions between UNG2, Vpr, IN as well as RT both in virus-producing cells and then in target cells.
###end p 16
###begin p 17
###xml 683 692 683 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 1145 1147 1145 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 301 306 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 443 448 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 758 763 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 999 1004 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1200 1229 <span type="species:ncbi:11673">feline immunodeficiency virus</span>
###xml 1231 1234 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1275 1279 <span type="species:ncbi:11660?0.9583333333333334">CAEV</span>
###xml 1285 1291 <span type="species:ncbi:9796">equine</span>
###xml 1311 1315 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 1612 1615 <span type="species:ncbi:11673?1.0">FIV</span>
###xml 1617 1621 <span type="species:ncbi:11660?0.9583333333333334">CAEV</span>
###xml 1625 1629 <span type="species:ncbi:11665?1.0">EIAV</span>
HIV-1 and other lentiviruses are unusual among retroviruses in their ability to infect resting or terminally differentiated cells. While Vpr has been shown to facilitate the nuclear import of viral DNA in non-dividing cells, the virion incorporation of UNG2 via Vpr also contributes to the ability of HIV-1 to replicate in primary macrophages. This implies that UNG2 is a cellular factor that plays an important role in the early steps of the HIV-1 replication cycle (i. e. viral DNA synthesis). This observation is in good agreement with a recent report showing that the misincorporation of uracil into minus strand viral DNA affects the initiation of the plus strand DNA synthesis in vitro [57]. This observation suggests that UNG is likely recruited into HIV-1 particles to subsequently minimize the detrimental accumulation of uracil into the newly synthesized proviral DNA. While further work is needed to explain the precise mechanism for how UNG catalytic activity may specifically influence HIV-1 replication in macrophages, it is worth noting that nondividing cells express low levels of UNG and contain relatively high levels of dUTP [58]. Similarly, most non-primate lentiviruses, such as feline immunodeficiency virus (FIV), caprine-arthritis-encephalitis virus (CAEV) and equine infectious anemia (EIAV), have also developed an efficient strategy to reduce accumulation of uracil into viral DNA. These lentiviruses encode and package a dUTP pyropshophatase (dUTPase) into virus particles, an enzyme that hydrolyzed dUTP to dUMP, and thus maintains a low level of dUTP. Interestingly, replication of FIV, CAEV or EIAV that lack functional dUTPase activity is severely affected in nondividing host cells (e.g., primary macrophages). Taken together, these results indicate that uracil misincorporation in viral DNA strands during reverse transcription is deleterious for the ongoing steps of the virus life cycle. The presence of a viral dUTPase or a cellular UNG will prevent these detrimental effects for replication of non-primate and primate lentiviruses in macrophages, respectively.
###end p 17
###begin p 18
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 77 82 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 480 485 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In addition, it is intriguing to note that two viral auxiliary proteins from HIV-1, Vpr and Vif, can both influence the fidelity of viral DNA synthesis. The Vif protein forms a complex with the cellular deaminase APOBEC-3G (CEM15) preventing its encapsidation into virions [59-63], while Vpr binds the DNA repair enzyme, UNG, to recruit it into the particles. It is tempting to speculate that the action of both viral proteins may influence the mutation rate during the course of HIV-1 infection, and their balance may play a key role during disease progression in infected individuals.
###end p 18
###begin title 19
Vpr and the nuclear import of the viral pre-integration complex
###end title 19
###begin p 20
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 1218 1220 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 1327 1329 1327 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1330 1332 1330 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 1453 1455 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 1456 1458 1456 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 401 406 <span type="species:ncbi:9606">human</span>
###xml 465 468 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 696 701 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1042 1045 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1050 1053 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Nondividing cells, such as resting T cells and terminally-differentiated macrophages, are important targets for viral replication during the initial stages of infection, since primary infection of these cell populations contributes to the establishment of virus reservoirs, crucial for subsequent virus spread to lymphoid organs and T-helper lymphocytes [64]. Infection of lymphoid histoculture using human tonsil or splenic tissue showed that Vpr greatly enhances HIV replication in macrophages but did not influence productive infection of proliferating or resting T cells [65]. After virus entry into the cell, the viral capsid is rapidly uncoated and the reverse transcription of the genomic HIV-1 RNA leading to the full length double-strand DNA is completed. This viral DNA associates with viral and host cell proteins into the so-called pre-integration complex (PIC). In contrast to oncoretroviruses which require nuclear envelope disintegration during mitosis to integrate their viral genome into host chromosomes, lentiviruses, such HIV and SIV, have evolved a strategy to import their own genome through the envelope of the interphasic nucleus via an active mechanism 4-6 h after infection (for review, see [66]). Vpr has been reported to enhance the transport of the viral DNA into the nucleus of nondividing cells [67-69], by promoting direct or indirect interactions with the cellular machinery regulating the nucleo-cytoplasmic shuttling [70-74].
###end p 20
###begin title 21
PIC en route to the NE
###end title 21
###begin p 22
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
The exact composition of the PIC is still an area of debate but it contains the viral DNA at least associated with integrase, and many recent studies have confirmed that Vpr is also an integral component of this complex (for reviews, see [75-77]). Of course, the PIC likely contains cellular factors that participate in both intra-cytoplasmic routing and nuclear translocation of the viral DNA. While actin microfilaments seem to play a role in the early events of infection by acting as a scaffold for the appropriate localization and activation of the RTC [78], the PIC is tightly associated with microtubular structures in the cytoplasm. An elegant system using Vpr fused to GFP as a probe was developed to follow the movement of the PIC soon after virus entry in living cells [40]. It has been shown that the GFP-Vpr labeled-PIC progresses throughout the cytoplasm along cytoskeletal filaments and then accumulates in the perinuclear region close to centrosomes. More precisely, it was observed that the viral complex uses the cytoplasmic dynein motor to travel along the microtubule network to migrate towards the nucleus. It is not yet known whether Vpr plays an active role during this movement of the PIC along microtubules or whether it is only associated with the complex and then actively participates in the subsequent steps, including the anchoring of the PIC to the nuclear envelope (NE) and the nuclear translocation of the viral DNA.
###end p 22
###begin title 23
Vpr docks at the NE
###end title 23
###begin p 24
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 1047 1049 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 1139 1141 1139 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 1312 1321 1312 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1537 1539 1537 1539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 2046 2048 2046 2048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 2049 2051 2049 2051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 2052 2054 2052 2054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
###xml 2197 2199 2197 2199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 2528 2530 2528 2530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 2531 2533 2531 2533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B88">88</xref>
###xml 904 909 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 980 985 <span type="species:ncbi:9606">human</span>
###xml 1031 1036 <span type="species:ncbi:4932">yeast</span>
###xml 1089 1094 <span type="species:ncbi:9606">human</span>
Indeed, Vpr displays evident karyophilic properties and localizes in the nucleus, but a significant fraction is anchored at the NE and can be visualized as a nuclear rim staining in fluorescence microscopy experiments [73,79-81]. The NE consists of two concentric inner and outer membranes studded with nuclear pore complexes (NPC) that form a conduit with a central aqueous channel which allows selective trafficking between the nucleus and cytoplasm and creates a permeability barrier to free diffusion of macromolecules or complexes. NPC corresponds to a 125-MDa structure consisting of 30 distinct nuclear pore proteins, named nucleoporins (Nups) [82]. A specific subset of Nups contain FG- or FxFG peptide repeats that constitute most of the filamentous structures emanating from both sides of the NPC and that provide docking sites for various transport factors [83]. Initial studies revealed that HIV-1 Vpr bound to the FG-rich region of several nucleoporins including the human p54 and p58 Nups, the rodent POM121, and the yeast NUP1P [71,73,74], but a direct interaction with the human CG1 nucleoporin was more recently reported [70]. This interaction is not mediated by the FG-repeat region of this Nup but rather via a region without consensus motif located in the N-terminus of the protein. Using an in vitro nuclear import assay, it has been demonstrated that the association with the N-terminal region of hCG1 is required for the docking of Vpr to the NE, whereas the FG-repeat region does not participate in this process [70]. The role of Vpr at the NE is not clear but two explanations can be proposed. First, this localization may account for the targeting of the PIC to the NPC before its translocation into the nuclear compartment. In this model, the virion-associated Vpr would be primarily involved, after virus entry and uncoating, in the initial docking step of the viral DNA to the NPC, while other karyophilic determinants of the PIC, such as IN, would then allow for the second step of nuclear translocation to proceed [81,84-86]. Alternatively, another explanation may come from the observation that Vpr was able to provoke herniations and transient ruptures of the NE [87]. The molecular mechanism supporting the local bursting induced by Vpr is not known but the interaction of Vpr with nucleoporins may cause initial misassembly of the NPC leading to alterations of the NE architecture. Consequently, these transient ruptures may provide an unconventional route for nuclear entry of the viral PIC [87,88].
###end p 24
###begin title 25
Translocation of Vpr into the nucleus
###end title 25
###begin p 26
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B89">89</xref>
###xml 310 319 310 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 469 471 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 472 474 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 475 477 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B90">90</xref>
###xml 478 480 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 637 639 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 640 642 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 768 770 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B95">95</xref>
###xml 771 773 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B96">96</xref>
###xml 855 857 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 858 860 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 1013 1015 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B92">92</xref>
###xml 1250 1252 1235 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B92">92</xref>
###xml 1253 1255 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 1452 1454 1433 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1455 1457 1436 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 1458 1460 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 1095 1100 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Despite the lack of any identifiable canonical nuclear localization signal (NLS), Vpr displays evident karyophilic properties and is rapidly targeted to the host cell nucleus after infection [89]. Even though the small size of Vpr does not strictly require an NLS-dependent process, experiments performed both in vitro or in transfected cells have shown that Vpr is able to actively promote nuclear import of a reporter protein, such as BSA, beta-galastosidase or GFP [10,13,90-94]. Like proteins containing a basic-type NLS, it was initially proposed that Vpr uses an importin alpha-dependant pathway to access the nuclear compartment [72,73]. In addition, Vpr may enhance the inherently low affinity of the viral MA for importin alpha to allow nuclear import of MA [95,96], but conflicting data exists on the nuclear localization of this viral protein [81,85]. Finally, it was reported that Vpr nuclear import was mediated by an unidentified pathway, distinct from the classical NLS- and M9-dependant pathways [92]. Two independent nuclear targeting signals have been characterized within the HIV-1 Vpr sequence, one spanning the alpha-helical domains in the N-terminal part of the protein and the other within the arginine-rich C-terminal region [92,94]. These results are consistent with data showing that the structure of the alpha-helical domains of Vpr must be maintained both for its nuclear localization and for Vpr binding with nucleoporins [25,70,80].
###end p 26
###begin p 27
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B97">97</xref>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B98">98</xref>
In conclusion, the nucleophilic property of Vpr and its high affinity for the NPC, associated with its presence in the viral PIC, at least support a role during the docking step of the PIC at the NE, a prerequisite before the translocation of viral DNA into the nucleus. Even though there is no evidence that Vpr directly participates in the translocation process, it is worth noting that purified PICs also dock at the NE before nuclear translocation using a pathway also distinct from the NLS and M9 nuclear import pathways [49]. One can suggest that among the redundancy of nuclear localization signals characterized within the PIC, both in associated viral proteins (i.e. IN, MA, Vpr) and also in the viral DNA [97], Vpr primarily serves to dock the PIC at the NE, while IN and MA act in cooperation with the central DNA flap to target the viral DNA to the nucleus (for review, see [98]).
###end p 27
###begin title 28
Vpr, a nucleocytoplasmic protein
###end title 28
###begin p 29
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B99">99</xref>
###xml 175 178 175 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B100">100</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B99">99</xref>
###xml 737 741 737 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 808 811 808 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B100">100</xref>
In addition to its nonconventional NLS for targeting into the nucleus, Vpr is a dynamic mobile protein able to shuttle between the nucleus and cytoplasmic compartments [23,99,100]. Photobleaching experiments on living cells expressing a Vpr-GFP fusion confirmed that Vpr displays nucleocytoplasmic shuttling properties [70]. This shuttling activity has been related to the distal leucine-rich helix which could form a classical CRM1-dependant nuclear export signal (NES) [99]. The exact role of this NES in the function of Vpr is not known but since Vpr is rapidly imported into the nucleus after biosynthesis, the NES could redirect it into the cytoplasm for subsequent incorporation into virions through direct binding to the viral p55Gag precursor during the late budding step of the virus life cycle [23,100].
###end p 29
###begin title 30
Vpr and the cell cycle
###end title 30
###begin p 31
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B91">91</xref>
###xml 205 208 205 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B101">101</xref>
###xml 209 212 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B105">105</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 344 347 344 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B106">106</xref>
###xml 500 509 500 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 534 548 534 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae </italic>
###xml 625 628 625 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B107">107</xref>
###xml 629 632 629 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B109">109</xref>
###xml 842 846 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpr </italic>
###xml 892 895 892 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B110">110</xref>
###xml 1163 1166 1163 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B111">111</xref>
###xml 43 46 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 51 54 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 500 508 <span type="species:ncbi:4896">S. pombe</span>
###xml 509 522 <span type="species:ncbi:4896">fission yeast</span>
###xml 534 547 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 563 568 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 783 819 <span type="species:ncbi:11660">caprine arthritis encephalitis virus</span>
###xml 821 825 <span type="species:ncbi:11660?0.9583333333333334">CAEV</span>
###xml 856 859 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 1002 1007 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1156 1161 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1268 1273 <span type="species:ncbi:9606">human</span>
A further important biological activity of SIV and HIV Vpr proteins is related to their ability to induce an arrest in the G2 phase of the cell cycle of infected proliferating human and simian T cells [91,101-105]. Cell cycle arrest does not require de novo synthesis of Vpr, but is induced by Vpr molecules packaged into infecting virions [87,106]. This indicates that induction of the G2 cell cycle arrest might happen before the integration step of the viral DNA genome. It is noteworthy that the S. pombe fission yeast as well as S. cerevisiae overexpressing HIV-1 Vpr are also blocked in the G2 phase of the cell cycle [107-109], supporting the idea that the cellular pathway altered by Vpr is well conserved in all eukaryotic cells. Moreover, infection of caprine cells with a caprine arthritis encephalitis virus (CAEV) expressing the vpr gene from SIV similarly provoked a G2 arrest [110]. The biological significance of this arrest during the natural infection is not well understood, but the HIV-1 LTR seems to be more active in the G2 phase, implying that the G2 arrest may confer a favorable cellular environment for efficient transcription of HIV-1 [111]. In agreement, the Vpr-induced G2 arrest correlates with high level of viral replication in primary human T cells.
###end p 31
###begin p 32
###xml 167 170 167 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B112">112</xref>
###xml 171 174 171 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B113">113</xref>
###xml 322 325 322 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B114">114</xref>
###xml 405 408 405 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B115">115</xref>
###xml 576 579 576 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B102">102</xref>
###xml 580 583 580 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B103">103</xref>
###xml 1124 1127 1124 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B101">101</xref>
###xml 1128 1131 1128 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B103">103</xref>
###xml 1585 1588 1585 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B116">116</xref>
###xml 1654 1657 1654 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B117">117</xref>
###xml 1953 1956 1953 1956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B116">116</xref>
###xml 1957 1960 1957 1960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B117">117</xref>
###xml 2344 2347 2344 2347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B118">118</xref>
###xml 2348 2351 2348 2351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B120">120</xref>
###xml 2493 2496 2493 2496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B121">121</xref>
###xml 2497 2500 2497 2500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B122">122</xref>
###xml 2769 2772 2769 2772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B123">123</xref>
###xml 2890 2893 2890 2893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B124">124</xref>
###xml 3030 3033 3030 3033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B125">125</xref>
###xml 109 114 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1561 1566 <span type="species:ncbi:4932">yeast</span>
###xml 2025 2030 <span type="species:ncbi:9606">human</span>
###xml 2048 2053 <span type="species:ncbi:4932">yeast</span>
The determinants of the G2 arrest activity are mainly located in the C-terminal unstructured basic region of HIV-1 Vpr and phosphorylation of the protein is required [112,113]. Regulators of the cell cycle, such as cyclin-dependant kinases (CDKs), control progression through the cell cycle by reversible phosphorylation [114]. The p34/cdc2 CDK associates with cyclin B1 in the G2 phase (for review, see [115]) to regulate the G2 to M transition. Accumulation of the cells expressing Vpr in the G2 phase has been correlated to the inactivation of the p34/cdc2-cyclinB kinase [102,103]. The activity of cdc2 is controlled by opposite effects of the Wee-1 and Myt1 kinases and the cdc25 phosphatase. Wee1 inhibits cdc2 activity through tyrosine phosphorylation, while dephosphorylation of cdc2 by the phosphatase cdc25 promotes cdc2-cyclinB activation that drives cells into mitosis. The activities of both cdc25 and Wee-1 are also regulated by phosphorylation/dephosphorylation. It was initially described that Vpr-expressing cells contained both hyperphosphorylated cdc2 and hypophosphorylated cdc25, their inactive status [101-103]. Consequently, these two regulators of the G2/M switch are blocked preventing any cell cycle progression. The molecular mechanism leading to this inhibition is not yet clear, but different cellular partners interacting with Vpr which could play a role in cell cycle regulation have been proposed as potential mediators of the Vpr-induced G2 arrest. hVIP/MOV34, a member of the eIF3 complex, was identified as a Vpr-partner in a yeast two-hybrid assay [116], and was associated with the cell cycle arrest activity of Vpr [117]. eIF3 is a large multimeric complex that regulates transcriptional events and is essential for both G1/S and G2/M progression. Intracellular localization studies revealed that expression of Vpr induces a relocalization of MOV34 that shifts from a cytoplasmic to a nuclear localization pattern [116,117]. Two other cellular partners of Vpr, UNG and HHR23A (i.e., the human homologue of the yeast rad23 protein), are implicated cellular DNA repair processes. Since a clear relationship exists between the DNA damage response pathway and the progression of the cell cycle, it was initially suggested that Vpr binding to these DNA repair proteins could account for the observed G2 arrest [118-120], but subsequent analyses indicated that there was no correlation between the association of Vpr with HHR23A and/or UNG and the block in G2 [121,122]. These analyses are in agreement with a previous report showing that the Vpr-mediated arrest is distinct from the cell cycle arrest in G2 related to DNA damage. However, it has also been reported that Vpr induces cell cycle arrest via a DNA damage-sensitive pathway [123]. The G2 DNA damage checkpoint is under the control of the phosphatidylinositol 3-kinase-like proteins, ATR and ATM [124], which lead to the inactivation of the cdc2-cyclinB complex. The ATR protein has been recently linked to the G2-arrest induced by Vpr [125]. Inhibition of ATR either by drugs, a dominant-negative form of ATR or by siRNA reverts the Vpr-induced cell cycle arrest while activation of ATR by Vpr results in Chk1 phosphorylation, the kinase regulating cdc25c activity. These authors suggested that the G2 arrest induced by Vpr parallels the ATR-DNA damage pathway, but additional work is needed to demonstrate that Vpr causes DNA damage or mimics a signal activating one of the DNA damage sensors.
###end p 32
###begin p 33
###xml 110 113 106 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B126">126</xref>
###xml 360 363 356 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B127">127</xref>
###xml 396 405 392 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 484 487 480 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B128">128</xref>
###xml 1229 1232 1217 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B129">129</xref>
###xml 1453 1455 1441 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 2112 2115 2100 2103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B130">130</xref>
###xml 2116 2119 2104 2107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B131">131</xref>
###xml 396 404 <span type="species:ncbi:4896">S. pombe</span>
The protein phosphatase 2A (PP2A) has been shown to be directly associated with Vpr via its B55alpha subunit [126]. PP2A is a serine/threonine phosphatase involved in a broad range of cellular processes, including cell cycle progression. PP2A inactivates cdc2 indirectly both by the inactivation of the Wee1 kinase and by activation of cdc25 (for review, see [127]). Genetic studies performed in S. pombe suggest the involvement of PP2A and Wee1 in the Vpr-induced cell cycle arrest [128]. Intriguingly, expression of Vpr and B55alpha results in the nuclear localization of B55alpha subunit while it remains cytoplasmic in normal condition. Together, these studies emphasized the fact that Vpr might play a role in the subcellular redistribution of several regulatory protein complexes involved in the progression of the cell cycle. Indeed, the mitotic function of cdc2-cyclinB complex is triggered not only by the turn of phosphorylation/desphorylation of both subunits on specific residues, but also by spatio-temporal control of their intracellular distribution. For example, cyclinB is predominantly cytoplasmic throughout the G2 phase until it translocates rapidly into the nucleus 10 min before nuclear envelope breakdown [129]. As mentioned earlier, Vpr induces herniations and local bursting of the nuclear envelope leading to redistribution of key cell cycle regulators, including Wee1, cdc25, and cyclin B into the cytoplasm of the host cell [87]. It seems evident that alterations of the subcellular localization of segregated cell cycle regulators could explain the G2 arrest induced by Vpr; this may also explain the overall variety of cellular factors that have been involved in this process. Alternatively, nuclear herniations induced by Vpr could also affect chromatin structure leading to the activation of ATR. However, it not known if the Vpr-induced alteration of the NE architecture could cause DNA damage such as double-strand breaks, but disruption of the nuclear lamin structure is sufficient to block DNA replication, another abnormality recognized by the ATR protein (for reviews, see [130,131]).
###end p 33
###begin title 34
Vpr and apoptosis
###end title 34
###begin p 35
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 180 182 180 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 368 371 368 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B132">132</xref>
###xml 647 656 647 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 818 821 818 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B133">133</xref>
###xml 950 953 950 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B134">134</xref>
###xml 954 957 954 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B135">135</xref>
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 262 265 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 514 517 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 678 693 <span type="species:ncbi:10090">transgenic mice</span>
HIV infection causes a depletion of CD4+ T cells in AIDS patients, which results in a weakened immune system, impairing its ability to fight infections. The major mechanism for CD4+ T cell depletion is programmed cell death, or apoptosis, that can be induced by HIV through multiple pathways of both infected cells and non-infected "bystander" cells (for review, see [132]). Even though the exact contribution of Vpr as a pro-apoptotic factor responsible for the T cell depletion observed in the natural course of HIV infection is still unknown, it was repeatedly evidenced that Vpr has cytotoxic potential and is able to induce apoptosis in many in vitro systems. In addition, transgenic mice expressing Vpr under the control of the CD4 promoter show both CD4 and CD8 T cell depletion associated with thymic atrophy [133]. However, controversial results indicating that Vpr can also act as negative regulator of T cell apoptosis have been reported [134,135].
###end p 35
###begin p 36
###xml 72 75 72 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B136">136</xref>
###xml 76 79 76 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B140">140</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 257 260 257 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B141">141</xref>
###xml 261 264 261 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B142">142</xref>
###xml 504 507 504 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B143">143</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 761 764 761 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B144">144</xref>
###xml 765 768 765 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B145">145</xref>
###xml 978 981 978 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B138">138</xref>
###xml 982 985 982 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B146">146</xref>
Initially proposed as a consequence of the prolonged cell cycle arrest [136-140], other investigations have then revealed that the Vpr-mediated G2 arrest was not a prerequisite for induction of apoptosis, suggesting that both functions are separated [79,87,141,142]. However, the recent observation that the activity of the cell cycle regulatory Wee-1 kinase is decreased in Vpr-induced apoptotic cells led to the hypothesis of a direct correlation between the G2 arrest and apoptotic properties of Vpr [143]. Hence, reduction of Wee-1 activity, probably related to its delocalization provoked by Vpr [87], results in an inappropriate activation of cdc2 leading to cell death with phenotypical aberrant mitotic features, a process known as mitotic catastrophe [144,145]. Using an established cell line expressing Vpr, it was observed that after the long G2 phase, cell rounded up with aberrant M-phase spindle with multiple poles resulting from abnormal centrosome duplication [138,146]. The cells stopped prematurely in pro-metaphase and died by subsequent apoptosis.
###end p 36
###begin p 37
###xml 336 338 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 694 696 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 697 700 691 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B147">147</xref>
###xml 1028 1030 1022 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c </italic>
###xml 1089 1091 1083 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c </italic>
###xml 1314 1317 1308 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B148">148</xref>
###xml 1441 1443 1435 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 1444 1446 1438 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 1447 1450 1441 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B137">137</xref>
###xml 1451 1454 1445 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B140">140</xref>
###xml 1455 1458 1449 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B147">147</xref>
###xml 1459 1462 1453 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B149">149</xref>
###xml 1586 1589 1580 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B150">150</xref>
###xml 1735 1738 1729 1732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B149">149</xref>
###xml 1713 1718 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
However, works from the G. Kroemer's group have then well established that synthetic Vpr, as well as truncated polypeptides, are able to induce apoptosis by directly acting on mitochondria leading to the permeabilization of the mitochondrial membrane and subsequent dissipation of the mitochondrial transmembrane potential (DeltaPsim) [56]. This direct effect of Vpr was related to its ability to interact physically with the adenine nucleotide translocator (ANT), a component of the permeability transition pore of mitochondria localized in the inner mitochondrial membrane. Since ANT is a transmembrane protein and presents a WxxF motif on the inner membrane face which is recognized by Vpr [56,147], this interaction implies that Vpr must first cross the outer mitochondria membrane to access ANT. The interaction between Vpr and ANT triggers permeabilization of the inner membrane followed by permeabilization of the outer mitochondrial membrane with consequent release of soluble intermembrane proteins, such as cytochrome c and apoptosis inducing factors, in the cytosol. Cytochrome c then associates with Apaf-1 in a complex with caspase-9 to create the apoptosome, allowing activation of effector caspases, such as caspase-3, and subsequently the final execution of the apoptotic process (for review, see [148]). While numerous reports have shown that Vpr mediated-apoptosis was associated with activation of caspase-9 and capase-3 [56,79,137,140,147,149], it is intriguing that Vpr was still able to induce cell death in embryonic stem cells lacking Apaf-1, caspase-9 and IAF [150]. These results suggest a model in which the direct action of Vpr on mitochondria may be sufficient to cause cell death in HIV-1 infected cells [149].
###end p 37
###begin p 38
###xml 78 87 78 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 308 311 308 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B151">151</xref>
###xml 675 678 675 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B152">152</xref>
###xml 788 791 788 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B153">153</xref>
###xml 293 296 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 378 383 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 393 401 <span type="species:ncbi:9606">patients</span>
###xml 485 493 <span type="species:ncbi:9606">patients</span>
###xml 963 968 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Although the causal role of Vpr in the induction of apoptosis is evident both in vitro and ex vivo, its real contribution with other viral determinants, such as gp120 envelope, Tat, Nef and the viral protease, in the physiopathology of AIDS needs to be further documented during the course of HIV infection [151]. However, it was recently revealed that long term non-progressor HIV-1 infected patients show a highest frequency of mutation at the position Arg77 of the Vpr protein than patients with progressive AIDS disease. Interestingly, this residue seems crucial for the capacity of the protein to induce apoptosis through permeabilization of the mitochondrial membrane [152]. Conversely, it was reported that mutation of the Leu64 residue enhanced the pro-apoptopic activity of Vpr [153], indicating that mutations affecting the C-terminal region of the protein may generate Vpr molecules with different pro-apoptotic potentials during the course of natural HIV-1 infection.
###end p 38
###begin p 39
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B154">154</xref>
###xml 221 224 221 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B155">155</xref>
###xml 390 393 390 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B156">156</xref>
###xml 394 397 394 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B158">158</xref>
###xml 798 799 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 800 803 796 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B157">157</xref>
###xml 804 807 800 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B159">159</xref>
###xml 808 811 804 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B160">160</xref>
###xml 95 98 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
###xml 360 363 <span type="species:ncbi:10116">rat</span>
###xml 368 373 <span type="species:ncbi:9606">human</span>
In addition, soluble Vpr protein is found in the sera as well as in the cerebrospinal fluid of HIV-infected patients, and was proposed to play a role related to its pro-apoptotic activity in AIDS-associated dementia [154,155]. The involvement of Vpr in these neurological disorders has been suggested, since recombinant Vpr has neurocytopathic effects on both rat and human neuronal cells [156-158]. Neurons killed by extracellular Vpr display typical features of apoptosis evidenced by direct activation of the initiator caspase-8 that will lead to subsequent activation of effector caspases. These effects have been linked to the property of the first amphipathic alpha-helix of Vpr to form cation-selective ion channels in planar lipid bilayers, causing a depolarization of the plasma membrane [6,157,159,160]. These observations indicate that Vpr can trigger apoptotic processes by different alternative pathways depending of the target cells.
###end p 39
###begin title 40
Nuclear role(s) of Vpr
###end title 40
###begin p 41
###xml 146 149 146 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B161">161</xref>
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B162">162</xref>
###xml 372 375 372 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B111">111</xref>
###xml 376 379 376 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B163">163</xref>
###xml 491 494 491 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B164">164</xref>
###xml 495 498 495 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B166">166</xref>
###xml 565 568 565 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 676 679 672 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B167">167</xref>
###xml 680 683 676 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B170">170</xref>
###xml 796 801 788 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Waf1 </sup>
###xml 805 814 797 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">survivin </italic>
###xml 815 818 807 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B171">171</xref>
###xml 819 822 811 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B173">173</xref>
###xml 930 933 922 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B168">168</xref>
###xml 965 968 957 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B174">174</xref>
###xml 969 972 961 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B175">175</xref>
###xml 997 1000 989 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B163">163</xref>
###xml 1001 1004 993 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B176">176</xref>
###xml 1100 1103 1092 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B177">177</xref>
###xml 1204 1206 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 524 529 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The first reported function of Vpr was a modest transcriptional activity on the viral LTR promotor as well as on heterologous cellular promotors [161,162]. While the connection between cell cycle arrest and LTR-transactivation by Vpr is not well understood, it was concluded that activation of the Vpr-induced viral transcription is secondary to its G2/M arrest function [111,163]. An increase transcriptional activity is indeed observed from the viral LTR in arrested cells expressing Vpr [164-166]. The transactivation of HIV-1 induced by Vpr is mediated through cis-acting elements, including NF-kappaB, Sp1, C/EBP and the GRE enhancer sequences found in the LTR promotor [167-170]. Also related to this activity, Vpr regulates the expression of host cell genes such as NF-kappaB, NF-IL-6, p21Waf1 and survivin [171-173]. Finally, Vpr seems also able to interact directly with the ubiquitous cellular transcription factor Sp1 [168], the glucocorticoid receptor [174,175], the p300 coactivator [163,176], and with the transcription factor TFIIB, a component of the basal transcriptional machinery [177]. This latter interaction is also mediated by a WxxF motif found within the TFIIB primary sequence [55].
###end p 41
###begin p 42
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 177 180 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 267 270 267 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B168">168</xref>
###xml 315 318 315 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B178">178</xref>
###xml 623 626 619 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B179">179</xref>
###xml 1041 1044 1029 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B174">174</xref>
###xml 1045 1048 1033 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B175">175</xref>
###xml 1170 1173 1158 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B175">175</xref>
###xml 1272 1275 1260 1263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">26 </sup>
###xml 1284 1287 1272 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">68 </sup>
###xml 1367 1370 1351 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B174">174</xref>
###xml 1371 1374 1355 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B180">180</xref>
###xml 705 710 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1356 1361 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Vpr displays high affinity for nucleic acids but no specific DNA sequence targeted by Vpr has been yet identified [19,29]. Interestingly, Vpr does not bind to the Sp1 factor or cis-acting elements alone but it associates with Sp1 in the context of the G/C box array [168], as well as in a ternary complex with p53 [178], indicating that Vpr might bind specific DNA sequence once associated with cellular partners to subsequently drive expression of both host cell and viral genes. Consistently, it has been reported that Vpr can directly bind to p300 via a LXXLL motif present in the C-terminal alpha-helix of the protein [179], suggesting that Vpr may act by recruiting the p300/CBP co-activators to the HIV-1 LTR promotor and thus enhance viral expression. Since p300 is a co-activator of NF-kappaB, Vpr can also mediate up-regulation of promotors containing NF-kappaB and NF-IL-6 enhancer sequences in primary T cells and macrophages. In addition, Vpr markedly potentiates glucocorticoid receptor (GR) action on its responsive promotors [174,175]. The Vpr-mediated LTR transcription was inhibited by the addition of the GR antagonist, RU486, in cultured macrophages [175]. That Vpr-mediated co-activation of the GR is distinct from the G2 arrest and required both LLEEL26 and LQQLL68 motifs contained within the first and third alpha-helical domains of HIV-1 Vpr [174,180].
###end p 42
###begin p 43
###xml 403 407 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vpr </italic>
###xml 490 493 490 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B181">181</xref>
###xml 133 138 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 374 379 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Vpr may also function as an adaptor molecule for an efficient recruitment of transcriptional co-activators (GRE, p300/CBP...) to the HIV-1 LTR promotor and thus enhances viral replication. Additionally, it may be involved in the activation of host cell genes inducing cellular pathways in relation with the AIDS pathogenesis. Indeed, cDNA microarray analysis using isogenic HIV-1 either with or without vpr expression revealed that Vpr induces up and down regulation of various cell genes [181].
###end p 43
###begin title 44
Conclusion
###end title 44
###begin p 45
###xml 173 181 173 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 157 162 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 560 563 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
By interfering with many distinct cellular pathways all along the virus life cycle, it is now evident that Vpr's contribution to the overall pathogenesis of HIV-1 infection in vivo is likely crucial. While major efforts have been made during the last years to define the molecular mechanisms and cellular targets of Vpr, additional work is needed for the complete understanding of its wide range of activities. An important issue now is to define the precise contribution of each activity to the viral replication and pathogenesis during the natural course of HIV infection. The involvement of Vpr in key processes of the early steps the viral life cycle (i.e., reverse transcription and nuclear import of the viral DNA) represents a good target for developing novel therapeutic strategies for AIDS therapy. In addition, this viral factor represents a valuable tool to elucidate many fundamental cellular processes.
###end p 45
###begin title 46
List of abbreviations
###end title 46
###begin p 47
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 5 33 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 35 38 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 40 69 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
HIV, human immunodeficiency virus; SIV, simian immunodeficiency virus; CypA, cyclophilin A; nup, nucleoporin; PIC, pre-integration complex; RTC, reverse transcription complex.
###end p 47
###begin title 48
Acknowledgements
###end title 48
###begin p 49
###xml 170 206 170 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">"Ensemble contre le SIDA/SIDACTION" </italic>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">"ANRS"</italic>
We thank Louis Mansky for critical review of the manuscript, Guillaume Jacquot, Serge Bouaziz and Nelly Morellet for the kind gift of the figures. E.L.R. is supported by "Ensemble contre le SIDA/SIDACTION" and the French Agency for AIDS Research ("ANRS").
###end p 49
###begin article-title 50
Evolution of the primate lentiviruses: evidence from vpx and vpr
###end article-title 50
###begin article-title 51
###xml 23 52 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 69 83 <span type="species:ncbi:9544">rhesus monkeys</span>
vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys
###end article-title 51
###begin article-title 52
###xml 35 49 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 55 84 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus
###end article-title 52
###begin article-title 53
Progression to AIDS in the absence of a gene for vpr or vpx
###end article-title 53
###begin article-title 54
###xml 54 57 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification
###end article-title 54
###begin article-title 55
###xml 56 61 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest
###end article-title 55
###begin article-title 56
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: molecular insights into its biological functions
###end article-title 56
###begin article-title 57
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
NMR structure of the (1-51) N-terminal domain of the HIV-1 regulatory protein Vpr
###end article-title 57
###begin article-title 58
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
NMR structure of the HIV-1 regulatory protein Vpr in H2O/trifluoroethanol. Comparison with the Vpr N-terminal (1-51) and C-terminal (52-96) domains
###end article-title 58
###begin article-title 59
###xml 22 57 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation
###end article-title 59
###begin article-title 60
The C-terminal domain of VPR adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain
###end article-title 60
###begin article-title 61
###xml 67 102 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1
###end article-title 61
###begin article-title 62
###xml 123 158 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr
###end article-title 62
###begin article-title 63
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain
###end article-title 63
###begin article-title 64
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
NMR structure of the HIV-1 regulatory protein VPR
###end article-title 64
###begin article-title 65
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structural characterization of the HIV-1 Vpr N terminus: evidence of cis/trans-proline isomerism
###end article-title 65
###begin article-title 66
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression
###end article-title 66
###begin article-title 67
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis
###end article-title 67
###begin article-title 68
###xml 64 99 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Efficient DNA transfection mediated by the C-terminal domain of human immunodeficiency virus type 1 viral protein R
###end article-title 68
###begin article-title 69
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells
###end article-title 69
###begin article-title 70
###xml 101 136 <span type="species:ncbi:11723">simian immunodeficiency viruses SIV</span>
###xml 146 149 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm)
###end article-title 70
###begin article-title 71
###xml 26 61 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor
###end article-title 71
###begin article-title 72
###xml 18 53 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nuclear export of human immunodeficiency virus type 1 Vpr is not required for virion packaging
###end article-title 72
###begin article-title 73
Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses
###end article-title 73
###begin article-title 74
###xml 89 124 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr
###end article-title 74
###begin article-title 75
###xml 95 130 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr
###end article-title 75
###begin article-title 76
###xml 13 48 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Isolation of human immunodeficiency virus type 1 cores: retention of vpr in the absence of p6(gag) [In Process Citation]
###end article-title 76
###begin article-title 77
###xml 64 99 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1
###end article-title 77
###begin article-title 78
###xml 42 77 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1
###end article-title 78
###begin article-title 79
Interactions of the C-terminus of viral protein R with nucleic acids are modulated by its N-terminus
###end article-title 79
###begin article-title 80
###xml 20 23 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr
###end article-title 80
###begin article-title 81
###xml 73 78 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion
###end article-title 81
###begin article-title 82
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells
###end article-title 82
###begin article-title 83
###xml 30 58 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect
###end article-title 84
###begin article-title 85
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein
###end article-title 85
###begin article-title 86
###xml 10 38 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 40 43 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 75 78 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1
###end article-title 86
###begin article-title 87
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex
###end article-title 87
###begin article-title 88
###xml 24 59 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 61 66 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 79 84 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
Replication of chimeric human immunodeficiency virus type 1 (HIV-1) containing HIV-2 integrase (IN): naturally selected mutations in IN augment DNA synthesis
###end article-title 88
###begin article-title 89
###xml 47 50 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Visualization of the intracellular behavior of HIV in living cells
###end article-title 89
###begin article-title 90
###xml 15 18 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Recruitment of HIV and its receptors to dendritic cell-T cell junctions
###end article-title 90
###begin article-title 91
###xml 47 82 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex
###end article-title 91
###begin article-title 92
###xml 69 104 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1
###end article-title 92
###begin article-title 93
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition
###end article-title 93
###begin article-title 94
###xml 32 67 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes
###end article-title 94
###begin article-title 95
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells [see comments]
###end article-title 95
###begin article-title 96
Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways
###end article-title 96
###begin article-title 97
###xml 23 58 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core
###end article-title 97
###begin article-title 98
###xml 18 23 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7
###end article-title 98
###begin article-title 99
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 130 135 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription
###end article-title 99
###begin article-title 100
###xml 31 66 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase
###end article-title 100
###begin article-title 101
###xml 21 56 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene
###end article-title 101
###begin article-title 102
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages
###end article-title 102
###begin article-title 103
###xml 101 109 101 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 65 70 <span type="species:ncbi:9606">human</span>
The interaction of Vpr with uracil DNA glycosylase modulates the human immunodeficienty virus type 1 in vivo mutation rates
###end article-title 103
###begin article-title 104
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 Vpr co-activator induces a conformational change in TFIIB
###end article-title 104
###begin article-title 105
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore
###end article-title 105
###begin article-title 106
Incorporation of uracil into minus strand DNA affects the specificity of plus strand synthesis initiation during lentiviral reverse transcription
###end article-title 106
###begin article-title 107
Roles of uracil-DNA glycosylase and dUTPase in virus replication
###end article-title 107
###begin article-title 108
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
###end article-title 108
###begin article-title 109
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
###end article-title 109
###begin article-title 110
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
###end article-title 110
###begin article-title 111
###xml 32 37 <span type="species:ncbi:9606">human</span>
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
###end article-title 111
###begin article-title 112
###xml 17 22 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Hypermutation of HIV-1 DNA in the absence of the Vif protein
###end article-title 112
###begin article-title 113
###xml 39 42 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Current strategies in the treatment of HIV infection
###end article-title 113
###begin article-title 114
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells
###end article-title 114
###begin article-title 115
Nuclear import of viral DNA genomes
###end article-title 115
###begin article-title 116
###xml 45 73 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
###end article-title 116
###begin article-title 117
###xml 35 70 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import
###end article-title 117
###begin article-title 118
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
###end article-title 118
###begin article-title 119
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1
###end article-title 119
###begin article-title 120
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex
###end article-title 120
###begin article-title 121
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Viral protein R regulates nuclear import of the HIV-1 pre-integration complex
###end article-title 121
###begin article-title 122
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection
###end article-title 122
###begin article-title 123
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex
###end article-title 123
###begin article-title 124
###xml 18 46 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Nuclear import of human immunodeficiency virus type-1 preintegration complexes
###end article-title 124
###begin article-title 125
Journey to the center of the cell
###end article-title 125
###begin article-title 126
###xml 19 24 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Viral protein R of HIV-1
###end article-title 126
###begin article-title 127
###xml 30 65 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 67 72 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton
###end article-title 127
###begin article-title 128
Studies with GFP-Vpr fusion proteins: induction of apoptosis but ablation of cell-cycle arrest despite nuclear membrane or nuclear localization
###end article-title 128
###begin article-title 129
###xml 38 73 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Two putative alpha-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms
###end article-title 129
###begin article-title 130
###xml 97 102 <span type="species:ncbi:9606">Human</span>
Cellular Distribution and Karyophilic Properties of Matrix, Integrase, and Vpr Proteins from the Human and Simian Immunodeficiency Viruses
###end article-title 130
###begin article-title 131
Proteomic analysis of the mammalian nuclear pore complex
###end article-title 131
###begin article-title 132
The nuclear pore complex as a transport machine
###end article-title 132
###begin article-title 133
###xml 10 15 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Efficient HIV-1 replication can occur in the absence of the viral matrix protein
###end article-title 133
###begin article-title 134
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 92 97 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex
###end article-title 134
###begin article-title 135
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A novel nuclear export activity in HIV-1 matrix protein required for viral replication
###end article-title 135
###begin article-title 136
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr
###end article-title 136
###begin article-title 137
###xml 10 13 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Virology. HIV - breaking the rules for nuclear entry
###end article-title 137
###begin article-title 138
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions
###end article-title 138
###begin article-title 139
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Arginine residues in the C-terminus of HIV-1 Vpr are important for nuclear localization and cell cycle arrest
###end article-title 139
###begin article-title 140
###xml 87 122 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr
###end article-title 140
###begin article-title 141
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways
###end article-title 141
###begin article-title 142
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity
###end article-title 142
###begin article-title 143
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A peptide derived from the N-terminal region of HIV-1 Vpr promotes nuclear import in permeabilized cells: elucidation of the NLS region of the Vpr
###end article-title 143
###begin article-title 144
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr
###end article-title 144
###begin article-title 145
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Heat-Shock Protein 70 Can Replace Viral Protein R of HIV-1 during Nuclear Import of the Viral Preintegration Complex
###end article-title 145
###begin article-title 146
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 genome nuclear import is mediated by a central DNA flap
###end article-title 146
###begin article-title 147
###xml 27 30 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Slipping through the door: HIV entry into the nucleus
###end article-title 147
###begin article-title 148
###xml 31 66 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr
###end article-title 148
###begin article-title 149
###xml 63 98 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages
###end article-title 149
###begin article-title 150
###xml 4 39 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle
###end article-title 150
###begin article-title 151
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
###end article-title 151
###begin article-title 152
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B
###end article-title 152
###begin article-title 153
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control
###end article-title 153
###begin article-title 154
Vpr-induced cell cycle arrest is conserved among primate lentiviruses
###end article-title 154
###begin article-title 155
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents
###end article-title 155
###begin article-title 156
###xml 33 36 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 41 44 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 64 69 <span type="species:ncbi:4932">yeast</span>
###xml 70 95 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeast Schizosaccharomyces pombe
###end article-title 156
###begin article-title 157
###xml 10 45 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 108 121 <span type="species:ncbi:4896">fission yeast</span>
###xml 122 147 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe
###end article-title 157
###begin article-title 158
###xml 43 78 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Genetic selection of peptide inhibitors of human immunodeficiency virus type 1 Vpr
###end article-title 158
###begin article-title 159
###xml 52 88 <span type="species:ncbi:11660">caprine arthritis encephalitis virus</span>
###xml 123 152 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Specific G2 arrest of caprine cells infected with a caprine arthritis encephalitis virus expressing vpr and vpx genes from simian immunodeficiency virus
###end article-title 159
###begin article-title 160
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo
###end article-title 160
###begin article-title 161
###xml 19 24 <span type="species:ncbi:9606">Human</span>
Phosphorylation of Human Immunodeficiency Virus Type 1 Vpr Regulates Cell Cycle Arrest
###end article-title 161
###begin article-title 162
###xml 33 36 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection
###end article-title 162
###begin article-title 163
Checkpoint pathways come of age
###end article-title 163
###begin article-title 164
Checking out the G(2)/M transition
###end article-title 164
###begin article-title 165
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 27 32 <span type="species:ncbi:9606">human</span>
HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle
###end article-title 165
###begin article-title 166
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Carboxyl terminus of hVIP/mov34 is critical for HIV-1-Vpr interaction and glucocorticoid-mediated signaling
###end article-title 166
###begin article-title 167
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 35 40 <span type="species:ncbi:4932">yeast</span>
HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr
###end article-title 167
###begin article-title 168
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair
###end article-title 168
###begin article-title 169
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme
###end article-title 169
###begin article-title 170
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr
###end article-title 170
###begin article-title 171
###xml 63 98 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 103 132 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 136 151 <span type="species:ncbi:9531">sooty mangabeys</span>
Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest
###end article-title 171
###begin article-title 172
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard
###end article-title 172
###begin article-title 173
S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function
###end article-title 173
###begin article-title 174
###xml 58 63 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R
###end article-title 174
###begin article-title 175
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A
###end article-title 175
###begin article-title 176
Type 2A protein phosphatase, the complex regulator of numerous signaling pathways
###end article-title 176
###begin article-title 177
###xml 25 38 <span type="species:ncbi:4896">fission yeast</span>
###xml 39 64 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 147 182 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of wee1, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr
###end article-title 177
###begin article-title 178
Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal
###end article-title 178
###begin article-title 179
Molecular biology. Beginning at the end
###end article-title 179
###begin article-title 180
Lamins: building blocks or regulators of gene expression?
###end article-title 180
###begin article-title 181
###xml 46 74 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS
###end article-title 181
###begin article-title 182
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 79 84 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
T cell apoptosis causes peripheral T cell depletion in mice transgenic for the HIV-1 vpr gene
###end article-title 182
###begin article-title 183
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [see comments]
###end article-title 183
###begin article-title 184
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS
###end article-title 184
###begin article-title 185
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest
###end article-title 185
###begin article-title 186
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation
###end article-title 186
###begin article-title 187
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Induction of M-phase arrest and apoptosis after HIV-1 Vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells
###end article-title 187
###begin article-title 188
###xml 60 95 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells
###end article-title 188
###begin article-title 189
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells
###end article-title 189
###begin article-title 190
###xml 43 78 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G(1) cell cycle arrest
###end article-title 190
###begin article-title 191
###xml 45 50 <span type="species:ncbi:9606">Human</span>
Induction of Apoptosis by the Vpr Protein of Human Immunodeficiency Virus Type 1 Occurs Independently of G(2) Arrest of the Cell Cycle
###end article-title 191
###begin article-title 192
###xml 48 83 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis
###end article-title 192
###begin article-title 193
Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates
###end article-title 193
###begin article-title 194
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase
###end article-title 194
###begin article-title 195
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr Induces Defects in Mitosis, Cytokinesis, Nuclear Structure, and Centrosomes
###end article-title 195
###begin article-title 196
###xml 103 108 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2
###end article-title 196
###begin article-title 197
The expanding role of mitochondria in apoptosis
###end article-title 197
###begin article-title 198
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway
###end article-title 198
###begin article-title 199
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mechanism of HIV-1 viral protein R-induced apoptosis
###end article-title 199
###begin article-title 200
Apoptosis in AIDS
###end article-title 200
###begin article-title 201
###xml 53 56 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis
###end article-title 201
###begin article-title 202
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Pro-apoptotic activity of HIV-1 auxiliary regulatory protein Vpr is subtype-dependent and potently enhanced by nonconservative changes of the leucine residue at position 64
###end article-title 202
###begin article-title 203
###xml 63 91 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency
###end article-title 203
###begin article-title 204
###xml 56 91 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1
###end article-title 204
###begin article-title 205
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons
###end article-title 205
###begin article-title 206
###xml 38 73 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons
###end article-title 206
###begin article-title 207
###xml 25 60 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 84 87 <span type="species:ncbi:10116">rat</span>
Effects of extracellular human immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures
###end article-title 207
###begin article-title 208
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers
###end article-title 208
###begin article-title 209
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
###xml 61 66 <span type="species:ncbi:9606">human</span>
Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells
###end article-title 209
###begin article-title 210
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
Human immunodeficiency virus vpr product is a virion-associated regulatory protein
###end article-title 210
###begin article-title 211
###xml 27 55 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Mutational analysis of the human immunodeficiency virus vpr open reading frame
###end article-title 211
###begin article-title 212
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator
###end article-title 212
###begin article-title 213
###xml 43 78 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines
###end article-title 213
###begin article-title 214
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages
###end article-title 214
###begin article-title 215
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 95 100 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection
###end article-title 215
###begin article-title 216
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific
###end article-title 216
###begin article-title 217
###xml 37 72 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat
###end article-title 217
###begin article-title 218
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro
###end article-title 218
###begin article-title 219
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 86 91 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA
###end article-title 219
###begin article-title 220
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Upregulation of survivin by HIV-1 Vpr
###end article-title 220
###begin article-title 221
###xml 61 96 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression
###end article-title 221
###begin article-title 222
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest
###end article-title 222
###begin article-title 223
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 64 69 <span type="species:ncbi:9606">human</span>
The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor
###end article-title 223
###begin article-title 224
###xml 63 68 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product
###end article-title 224
###begin article-title 225
Viral replication and the coactivators p300 and CBP
###end article-title 225
###begin article-title 226
###xml 4 39 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB
###end article-title 226
###begin article-title 227
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription
###end article-title 227
###begin article-title 228
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 95 100 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators
###end article-title 228
###begin article-title 229
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest [In Process Citation]
###end article-title 229
###begin article-title 230
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Differential regulation of host cellular genes by HIV-1 viral protein R (Vpr): cDNA microarray analysis using isogenic virus
###end article-title 230

